BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19615551)

  • 1. Hidradenitis suppurativa and associated factors: still unsolved problems.
    Matusiak L; Bieniek A; Szepietowski JC
    J Am Acad Dermatol; 2009 Aug; 61(2):362-5. PubMed ID: 19615551
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic associations of hidradenitis suppurativa.
    Kohorst JJ; Kimball AB; Davis MD
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.
    Revuz JE; Canoui-Poitrine F; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Roujeau JC; Bonnelye G; Grob JJ; Bastuji-Garin S
    J Am Acad Dermatol; 2008 Oct; 59(4):596-601. PubMed ID: 18674845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology.
    Micheletti RG
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S48-50. PubMed ID: 25188457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
    Sartorius K; Emtestam L; Jemec GB; Lapins J
    Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
    Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
    J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
    Garg A; Birabaharan M; Strunk A
    J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and rural health--a neglected risk factor for knee osteoarthritis.
    Teichtahl AJ; Wang Y; Cicuttini FM
    Rural Remote Health; 2007; 7(1):698. PubMed ID: 17352628
    [No Abstract]   [Full Text] [Related]  

  • 10. Rethinking the female predominance in hidradenitis suppurativa.
    Choi E; Chandran NS
    Int J Dermatol; 2019 Mar; 58(3):e57-e58. PubMed ID: 30506675
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis: common pathways between hidradenitis suppurativa and Crohn disease.
    García Martínez FJ; Menchén L
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():13-20. PubMed ID: 28081764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa: a review of cause and treatment.
    Yazdanyar S; Jemec GB
    Curr Opin Infect Dis; 2011 Apr; 24(2):118-23. PubMed ID: 21192260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
    Shlyankevich J; Chen AJ; Kim GE; Kimball AB
    J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing patients with hidradenitis suppurativa.
    Ball SL; Tidman MJ
    Practitioner; 2016 May; 260(1793):25-9, 3. PubMed ID: 27382916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
    Esmann S; Dufour DN; Jemec GB
    Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
    Vekic DA; Frew J; Cains GD
    Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association between Hidradenitis Suppurativa and Crohn's Disease: in Search of the Missing Pathogenic Link.
    van der Zee HH; Horvath B; Jemec GBE; Prens EP
    J Invest Dermatol; 2016 Sep; 136(9):1747-1748. PubMed ID: 27542293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa: Epidemiology and scope of the problem.
    Jemec GB; Kimball AB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa.
    Rondags A; van Straalen KR; Arends S; van der Zee HH; Prens EP; Spoorenberg A; Horváth B
    J Am Acad Dermatol; 2019 Feb; 80(2):551-554.e1. PubMed ID: 30554892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.